Navigation Links
Carmel Pharma Introduces PhaSeal Secondary Set (C60)
Date:11/1/2009

New Component Streamlines Safe Spiking, Priming and IV Bag Infusion with Hazardous Drugs

Columbus, OH (Vocus) October 31, 2009 -- Carmel Pharma, maker of the PhaSeal System for the safe handling of hazardous drugs, now offers the Secondary Set (C60) for safe, streamlined preparation and administration of IV bag infusions.

For safety and ease of use, the non-vented Secondary Set offers the following features:

 
  • Drip chamber (20 drops/mL)
  • Flow stop to facilitate priming of the Secondary Set from the bag prior to adding the drug
  • Universal spike with built-in PhaSeal Connector for safe, leakproof transfer of the drug to the IV bag
  • DEHP-free PVC tubing (40 in.)

For more information or to order, call 866-487-9250 or visit www.PhaSeal.com.

PhaSeal is more than a system for the safe handling of hazardous drugs. It's the only clinically proven closed-system drug transfer device (CSTD) available today and is validated by more than 10 independent, peer-reviewed, published clinical studies. Distinguished by prominent thought leaders as the "Gold Standard" in safe handling, PhaSeal's airtight Expansion Chamber and leakproof Double Membrane connections prevent exposure to hazardous drugs, including aerosols and vapors, and make it the only system that meets the National Institute for Occupational Safety and Health (NIOSH) and International Society of Oncology Pharmacy Practitioners (ISOPP) definition of a true CSTD. Its
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. Carmel Pharma Introduces PhaSeal Secondary Set (C60)
2. VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference
3. Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009
4. China Pharma Holdings, Inc. to Report Third Quarter 2009 Financial Results on November 12, 2009
5. Cardinal Health Foundation, The Ohio State University College of Pharmacy Join Forces to Prevent Prescription Medication Abuse
6. WuXi PharmaTech Schedules Third-Quarter 2009 Earnings Release
7. 5 Steps to Pharmaceutical Marketing Happiness
8. Amira Pharmaceuticals to Present at the BIO Investor Forum in San Francisco
9. Vestara Awarded MedAssets Supplier Contract For Automated Pharmaceutical Waste Management Solution
10. CVS/pharmacy Rewards Shoppers For Passing on Plastic Bags
11. Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Carmel Pharma Introduces PhaSeal Secondary Set (C60) 
(Date:8/3/2015)... ... August 03, 2015 , ... Catalent Pharma Solutions, the ... and consumer health products, today welcomed the announcement by OPKO Health that the ... for a new treatment for chronic kidney disease (CKD) and vitamin D insufficiency, ...
(Date:8/3/2015)... ... August 03, 2015 , ... Novatus, Inc. today launched ... solution, as well as announced the date of its next major release. , ... contract management tasks as well as enhancements to the customer experience. Users ...
(Date:8/3/2015)... ... August 03, 2015 , ... Sensato and ... “Designing Secure Healthcare Systems” This three-day, highly interactive and immersive workshop, has ... with access to the tactics, techniques and practices required to design and develop ...
(Date:8/3/2015)... CA (PRWEB) , ... August 03, 2015 , ... A ... Pain: Injection of Stem Cells Found to Release Natural Painkiller That Can Last 'For ... in patients. According to the report, the new study showed that harvesting stem cell-rich ...
(Date:8/3/2015)... CA (PRWEB) , ... August 03, 2015 , ... ... global insurance brokerage firm, announced today that Joe Williams has joined its growing ... sales, and delivering HUB's differentiated service model to his clients. Mr. Williams will ...
Breaking Medicine News(10 mins):Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:Novatus Unveils Milestone Software Release 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 4Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2
... Following the,successful OCEANE bond issue, completed last Friday, ... Quantel signed on September 18th a,definitive agreement with ... GmbH, its subsidiary specialized in,dermatology-aesthetics lasers. Conditions ... a EUR4.6 million fixed portion and a,variable portion ...
... Sept. 19 If you,ve been experiencing watery,eyes and ... the,rise in the U.S., with an estimated 50 million ... to the tune of 3 billion,dollars a year, often ... say in-vitro blood tests, the latest generation of,allergy tests, ...
... for diseases such as diabetes and Alzheimer,s , WEDNESDAY, Sept. ... adult stem cells from the testes of male mice into ... contractile cardiac tissue, and brain cells. , If the same ... they may offer a source of new therapies to treat ...
... 20, 2007) -- Easily accessed and plentiful, adult stem cells ... to create a wide range of tissue types to help ... controversial embryonic stem cells. , That,s the promise of a ... Cornell Medical College in New York City, who report their ...
... access to high-quality, evidence-based care for behavioral health,conditions ... The,"Mental Health Parity Act of 2007" would require ... parity with respect to all financial,requirements and all ... "AHIP applauds the Senate for coming together ...
... When Michael Murphy of,Seymour, Iowa, was handed the ... of the September 15th Iowa vs. Iowa State,football game, ... Ride, Iowa",raffle. The Iowa Farm Bureau donated all proceeds ... (tickets were $10 each) to the American,Lung Association of ...
Cached Medicine News:Health News:QUANTEL Finalizes the Acquisition of WaveLight Aesthetic GmbH 2Health News:Stem Cells From Testes Produce Wide Range of Tissue Types 2Health News:Stem cells in adult testes provide alternative to embryonic stem cells for organ regeneration 2Health News:Stem cells in adult testes provide alternative to embryonic stem cells for organ regeneration 3Health News:Stem cells in adult testes provide alternative to embryonic stem cells for organ regeneration 4Health News:Renewable Fuel Chopper Raffle Nets $113,000 for American Lung Association Clean Air Choice Program 2
(Date:8/3/2015)... CORAL SPRINGS, Florida , August 3, ... and development agreements between biotech companies, military ... biotech solutions & therapies with regards to ... to positive clinical enhancements for regenerative medicine ... with recent developments, partnerships and advancements in ...
(Date:8/3/2015)... -- Biosensors International Group, Ltd. ("Biosensors" or the ... a developer, manufacturer and marketer of innovative medical ... fiscal quarter ended 30 June 2015 ("Q1 FY16"). ... , Biosensors continued to make ... by lower operating expenses and operational improvement. Operating ...
(Date:8/3/2015)... -- Array BioPharma Inc. (NASDAQ: ARRY ) today ... year of its fiscal year ended June 30, ... Array, noted, "Binimetinib and encorafenib, two innovative oncology ... regulatory submissions in 2016. Additional data shared over ... cancer further validate the value of these programs ...
Breaking Medicine Technology:Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 2Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 3Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 4Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 5Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 6Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 2Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 3Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 4Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 5Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 6Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 2Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 3Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 4Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 5Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 6Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 7Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 8Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 9Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 10Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 11Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 12
... ATLANTA, Dec. 6, 2010 GeoVax Labs, Inc. (OTC Bulletin ... company developing human vaccines for HIV/AIDS (HIV-1, Human Immunodeficiency Virus), ... of Directors effective January 1, 2011. Donald G. Hildebrand is ... as a Director and continue to serve as a consultant ...
... Obesity Society (TOS) and the Obesity Action Coalition (OAC) today ... the urgent need for more tools to address the obesity ... an advisory panel to review a new treatment for obesity. ... Advisory will review a New Drug Application for Contrave, for ...
Cached Medicine Technology:David A. Dodd Appointed Chairman of the Board of GeoVax Labs 2David A. Dodd Appointed Chairman of the Board of GeoVax Labs 3David A. Dodd Appointed Chairman of the Board of GeoVax Labs 4Obesity Organizations Call for a Full and Fair Hearing When the FDA Reviews New Treatments for Obesity 2
Uvex Patriot Frame...
... are designed with the safety and comfort of ... RS-520 (also called SF-6) leaded glass, the industry ... standards, as set for optical clarity, visible light ... eyewear is protecting your eyes, it also helps ...
... Goggles fit over glasses ... by the whole department! ... 1.0 mm leaded glass ... scatter radiation protection. Clear ...
Qualcraft™ Radiation Protection Eyewear, Metal, Bifocal. Provides maximum comfort and eye protection! Plano (nonprescription). Black with bronze temple bar....
Medicine Products: